Uzedy injection care in NYC

Nao Medical can coordinate psychiatric injection care with your prescribing psychiatrist. Share the current order, exact medicine, last dose date and treatment history through the confirmed clinical intake process. The clinicians review product-specific initiation or restart requirements and arrange medication delivery, administration and follow-up. Keep your existing treatment plan until the next appointment is agreed.

Uzedy is a long-acting risperidone injection given under the skin of the abdomen or upper arm. For adults with schizophrenia, the prescribed schedule may be monthly or every two months. For maintenance treatment of bipolar I disorder, the label uses monthly dosing, either alone or with lithium or valproate. The two-month option is not recommended for bipolar I maintenance.

The prescriber establishes tolerability with oral risperidone and reviews the current dose, diagnosis and interacting medicines. Kidney or liver impairment requires oral titration and a specific reduced injection plan. Review previous movement symptoms, prolactin effects, metabolic health, fainting and pregnancy considerations before starting.

The clinician selects the strength and interval from the oral risperidone treatment or the specified prior injection. Discuss which symptoms need maintenance treatment and whether the proposed frequency fits your care.

For a labelled start from oral risperidone, Uzedy is started after the last oral dose without a loading injection or routine oral supplementation. The current label also contains a specific transition from another risperidone IM injection given every two weeks. That sequence must not be generalized to every LAI.

Document the product, strength, date and next appointment. Report a persistent or troublesome lump, itching, restlessness, changes in movement or mood, and changes in daily function.

If a dose is missed, the label says to give the next injection as soon as possible and not more often than recommended. Contact the treating team so the actual date, symptoms and diagnosis-specific interval are reviewed. Report adverse effects between injections, particularly severe restlessness or changes in sexual function or periods.

The prescriber establishes tolerability with oral risperidone and reviews the current dose, diagnosis and interacting medicines. Kidney or liver impairment requires oral titration and a specific reduced injection plan. Review previous movement symptoms, prolactin effects, metabolic health, fainting and pregnancy considerations before starting.

A switch needs the responsible psychiatrist's documented plan, not just an administration appointment. Review the exact current product, strength, last dose, response and tolerability. The new injection has its own indication, prior-treatment, loading or oral-coverage rules. Ask whether Nao provides the prescribing evaluation or accepts an outside order, and confirm delivery, the administering site and follow-up before changing treatment. Do not stop or convert medicines yourself.

Continuing antipsychotic care reviews symptoms, daily function, injection dates, movement symptoms, sedation, falls, weight, blood pressure and medicine-specific blood tests. Blood sugar/lipids, prolactin or heart-rhythm assessment may be relevant depending on the product and history. Ask the psychiatrist which tests are due and who reviews them. An administration-only visit does not replace that care. Report new involuntary movements, marked restlessness, fainting or troublesome injection-site changes promptly.

The reviewed current US prescribing information for Uzedy does not specify a restricted REMS administration/distribution program. That does not remove the medicine’s prescribing, administration, initiation or monitoring requirements. Confirm the exact product and current FDA status with the treating clinician and dispensing service; a manufacturer access program is not itself an FDA REMS.

Coverage needs checking for the exact prescription and diagnosis. Ask which benefit pays for the drug, whether authorization or a specified pharmacy is required, and what you owe for medication, administration and psychiatric follow-up. For schizophrenia the labeled interval can be monthly or every two months; bipolar I maintenance uses monthly dosing. Confirm that the requested regimen matches the order being reviewed. A service listing or an approved office visit does not guarantee drug coverage or delivery.

A nodule can occur with this formulation. Do not rub or massage it. Contact the treating team if it is troublesome, worsening or accompanied by other concerning symptoms.

Movement symptoms, including akathisia, need prompt review. Tell the clinician if you cannot sit still or the symptom interferes with sleep or work. Do not change the injection or add a medicine yourself.

A healthcare professional gives Uzedy under the skin of the abdomen or upper arm. It must not be injected into a muscle or vein, and you should not give it to yourself. The prescriber selects the product-specific strength and interval after establishing oral risperidone tolerability. A labeled start from oral risperidone does not require a loading injection or routine oral supplementation. Keep the prescribed start or transition plan; those instructions differ from other risperidone injections.